Paeds Cases · rheumatology-musculoskeletal-and-sports
Scleroderma, mixed connective-tissue disease and overlap syndromes: Case
Clinical long case of a six-year-old boy presenting with the linear scleroderma of the right lower limb, covering the recognition of the active localised disease, the Zulian classification, the methotrexate first-line therapy with the corticosteroid bridging, the physiotherapy for the contracture, and the contrast with the juvenile systemic sclerosis and the mixed connective-tissue disease across the spectrum.
On this page
Study tools
Target exams
Framing the case
This six-year-old boy has the classic presentation of the linear scleroderma, the commonest subtype of the juvenile localised scleroderma. The band of hard, shiny skin crossing the right knee, the five-month duration, the violaceous active edge, and the loss of the full extension together declare the active linear disease, and the limp is the functional consequence of the tethered joint. The framework that organises the case is the localised scleroderma, the skin-confined family, and the urgent need to halt the active inflammation before the contracture fixes in the growing child. [6][7]
Immediate assessment and the classification
The assessment begins with the recognition that this is the localised and not the systemic disease. The absence of the Raynaud phenomenon, the sclerodactyly, the nailfold changes and the systemic symptoms places the lesion in the localised family, and the band morphology places it in the linear subtype. The Zulian classification, drawn from the seven hundred and fifty children, sorts the localised disease into the circumscribed morphea, the linear scleroderma, the generalised morphea, the pansclerotic morphea and the mixed morphea, and the linear subtype is the commonest in children, around two-thirds. The band is photographed and mapped, the joint range is measured, and the limb length is compared for the asymmetry. [6][8]
References6ShowHide
- [1]Foeldvari I, Pain CE Juvenile systemic sclerosis Best Pract Res Clin Rheumatol, 2026.PMID 41638996
- [6]Zulian F, Athreya BH, Laxer R, et al. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study Rheumatology (Oxford), 2006.PMID 16368732
- [7]Martini G, Fadanelli G, Agazzi A, Vittadello F, Meneghel A, Zulian F Disease course and long-term outcome of juvenile localized scleroderma: Experience from a single pediatric rheumatology Centre and literature review Autoimmun Rev, 2018.PMID 29729451
- [9]Kaushik A, Mahajan R, De D, et al. Paediatric morphoea: a holistic review. Part 2: diagnosis, measures of disease activity, management and natural history Clin Exp Dermatol, 2020.PMID 32449205
- [8]Kaushik A, Mahajan R, De D, et al. Paediatric morphoea: a holistic review. Part 1: epidemiology, aetiopathogenesis and clinical classification Clin Exp Dermatol, 2020.PMID 32472964
- [10]Chevalier K, Bader-Meunier B, Kone-Paut I, Terrier B, Hachulla E, Mouthon L, Chaigne B, Costedoat-Chalumeau N Juvenile-onset mixed connective tissue disease: A multicenter retrospective cohort study Semin Arthritis Rheum, 2026.PMID 41412094